146 Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1

• Mark M Davis,
• Alice Bertaina,
• Alma-Martina Cepika,
• Pauline P Chen,
• Molly Uyeda,
• Brandon Cieniewicz,
• Mansi Narula,
• Laura Amaya,
• David M Louis,
• Liwen Xu,
• Xuhuai Ji,
• Rajni Agarwal-Hashmi,
• Everett Meyer,
• Rosa Bacchetta,
• Maria Grazia Roncarolo

Affiliations

Mark M Davis

Stanford University School of Medicine, Stanford, CA, USA

Alice Bertaina

Aff1 grid.414125.70000000107276809Pediatric Hematology/OncologyIRCCS Bambino Gesù Children's Hospital Rome Italy

Alma-Martina Cepika

Stanford University School of Medicine, Stanford, CA, USA

Pauline P Chen

Stanford University School of Medicine, Stanford, CA, USA

Molly Uyeda

Stanford University School of Medicine, Stanford, CA, USA

Brandon Cieniewicz

Stanford University School of Medicine, Stanford, CA, USA

Mansi Narula

Stanford University School of Medicine, Stanford, CA, USA

Laura Amaya

Stanford University School of Medicine, Stanford, CA, USA

David M Louis

Stanford University School of Medicine, Stanford, CA, USA

Liwen Xu

Stanford University School of Medicine, Stanford, CA, USA

Xuhuai Ji

Stanford University School of Medicine, Stanford, CA, USA

Rajni Agarwal-Hashmi

Stanford University School of Medicine, Stanford, CA, USA

Everett Meyer

Stanford University School of Medicine, Stanford, CA, USA

Rosa Bacchetta

Stanford University School of Medicine, Stanford, CA, USA

Maria Grazia Roncarolo

Stanford University School of Medicine, Stanford, CA, USA